Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES:
Evaluate the safety and efficacy of collagenase in improving flexion deformity, range of
motion, and grip strength in patients with residual Dupuytren's disease.